What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials?

Yu Shyr, Derek Shyr

Research output: Contribution to journalEditorialpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)1334-1335
Number of pages2
JournalJAMA Oncology
Volume6
Issue number9
DOIs
Publication statusPublished - 2020 Sep

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this